Anti-CCL3 / MIP-1 alpha antibody
4
(1 Review)
|
(9 Publications)
Rabbit Polyclonal MIP-1 alpha/CCL3 antibody. Suitable for IHC-P and reacts with Human samples. Cited in 9 publications.
View Alternative Names
G0S19-1, MIP1A, SCYA3, CCL3, C-C motif chemokine 3, G0/G1 switch regulatory protein 19-1, Macrophage inflammatory protein 1-alpha, PAT 464.1, SIS-beta, Small-inducible cytokine A3, Tonsillar lymphocyte LD78 alpha protein, MIP-1-alpha
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Proteins including MIP-1 alpha participate in the recruitment and activation of diverse immune cells aiding the inflammatory response. Through interaction with receptors like CCR1 and CCR5 MIP-1 alpha mobilizes cells like natural killer cells and monocytes. This chemokine does not generally form part of a larger protein complex but interacts directly with membrane receptors to exert its function in immune cell chemotaxis.
Pathways
MIP-1 alpha operates in the context of both the inflammatory response and the chemokine signaling pathways. Its involvement in these pathways helps mediate the trafficking of leukocytes. Notably MIP-1 alpha interacts with proteins such as CCR1 and CCR5 to transmit signals that instigate immune responses. These proteins are integral to its role in modulating immunity providing targets for research into controlling inflammatory processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (9)
Recent publications for all applications. Explore the full list and refine your search
BMC medicine 23:213 PubMed40223064
2025
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 12:e2406684 PubMed39465672
2024
Applications
Unspecified application
Species
Unspecified reactive species
Contrast media & molecular imaging 2022:2387192 PubMed35935327
2022
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 12:4977 PubMed34404786
2021
Applications
Unspecified application
Species
Unspecified reactive species
JOR spine 3:e1098 PubMed33015573
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cells 9: PubMed32183151
2020
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of clinical investigation 130:1156-1167 PubMed32015229
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 25:2163-2176.e6 PubMed30463013
2018
Applications
Unspecified application
Species
Unspecified reactive species
International journal of oncology 40:1995-2003 PubMed22307528
2012
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com